Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research & development, production and distribution of pharmaceuticals as well as Chinese herbal medicines. Its products include wuling powder, wuling capsule, linglianhua particle, clindamycin phosphate injection, doxapram injection, pefloxacin mesylate injection, azithromycin injection and sodium nitroprusside injection. The company was founded on January 28, 2000 and is headquartered Huzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company